Tissue Regenix Brings in $39M To Advance dCell Technology

LONDON  Closing the year with some cheer for the sector, Tissue Regenix Group plc has raised £25 million (US$39 million) in a placing, enabling the regenerative medicine specialist to begin to advance several programs in parallel.